Full-Body MRI Screening (Prenuvo) — Diagnostics & Biomarker Testing
Whole-body MRI scan for early detection of cancer, vascular anomalies, organ abnormalities, and other pathology — a preventive imaging tool gaining adoption in longevity medicine.
Overview
Full-body MRI screening uses multi-sequence magnetic resonance imaging to evaluate the brain, spine, chest, abdomen, and pelvis in a single ~60-90 minute scan without ionizing radiation. Prenuvo is the leading commercial provider, having scanned tens of thousands of asymptomatic individuals. A 2023 Nature Medicine study of 5,000+ asymptomatic Prenuvo participants found that 24% had at least one finding leading to a clinical action, with 1 in 20 having something considered significant. Findings include renal cell carcinomas, pancreatic lesions, brain tumors, aortic aneurysms, liver pathology, and spinal cord abnormalities. Peter Diamandis, Kevin Durant, and numerous Silicon Valley executives have popularized the scan. Critics note overdiagnosis concerns, high false positive rates for incidental findings, and the psychological burden of incidentalomas. MRI does not image all cancers well — dense breast tissue, prostate cancer, and some lung cancers may require complementary testing.
Indications
- Early cancer detection in asymptomatic individuals
- Cardiovascular structural abnormality screening
- Neurological abnormality detection
- Organ health baseline assessment
- High-risk individuals (family history of cancer, BRCA carriers)
Mechanism of Action
Different MRI pulse sequences (T1, T2, DWI, FLAIR) highlight different tissue properties, enabling simultaneous evaluation of solid organs, vasculature, brain, and spine
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Full-Body MRI | 60-90 min scan (brain, spine, chest, abdomen, pelvis) | Every 1-2 years | No radiation; no contrast in standard Prenuvo protocol; some providers add gadolinium for enhanced soft tissue detail |
Evidence Grade
GRADE C
Safety & Contraindications
- No ionizing radiation — MRI uses magnetic fields and radio waves only
- Incidentaloma burden: 24% of scans find actionable findings; many require follow-up imaging or biopsy, causing anxiety and additional procedures
- Claustrophobia may require open-bore MRI or anxiolytic premedication
- Contraindicated with ferromagnetic metallic implants (some pacemakers, cochlear implants, aneurysm clips)
- Contrast agents (gadolinium) used in some protocols carry small risk of nephrogenic systemic fibrosis in patients with severe renal impairment
- Cost ($2,500-$3,500) is not covered by insurance for asymptomatic screening